Mesoblast director Cobley reports initial MESO holdings

Mesoblast Ltd director Lynette Elizabeth Cobley filed an initial Form 3 showing her existing equity stake.

Rhea-AI Filing Summary

Mesoblast Ltd director Lynette Elizabeth Cobley filed an initial Form 3 showing her existing equity stake. She reports 30,000 Ordinary Shares held directly and 33,000 Ordinary Shares held indirectly through Synergy Finance Pty Ltd as trustee for her self-managed superannuation fund. She also holds an option over 200,000 Ordinary Shares at an exercise price of $1.72 per share, expiring on May 9, 2032. According to the footnote, these options were granted on May 10, 2025 and vest in three annual tranches through 2028.

Insider Trade Summary

3 transactions reported

Mixed 3 txns

Insider COBLEY LYNETTE ELIZABETH

Role Director

Type	Security	Shares	Price	Value
holding	Option (right to buy)	--	--	--
holding	Ordinary Shares	--	--	--
holding	Ordinary Shares	--	--	--

Holdings After Transaction: Option (right to buy) — 200,000 contracts (Direct); Ordinary Shares — 30,000 shares (Direct); Ordinary Shares — 33,000 shares (Indirect, By Synergy Finance Pty Ltd as trustee for Ms Cobley's self-managed superannuation fund.)

Footnotes (1)

1. F1. Granted on May 10, 2025. 66,667 options will vest on May 10, 2026, 66,667 options will vest on May 10, 2027, and 66,666 options will vest on May 10, 2028.

Key Figures

Direct Ordinary Shares: 30,000 shares Indirect Ordinary Shares: 33,000 shares Options underlying shares: 200,000 shares +5 more

8 metrics

Direct Ordinary Shares 30,000 shares Direct ownership reported on Form 3

Indirect Ordinary Shares 33,000 shares Held via Synergy Finance Pty Ltd as trustee

Options underlying shares 200,000 shares Underlying Ordinary Shares for reported option holding

Option exercise price $1.72 per share Exercise price of Option (right to buy)

Option expiration May 9, 2032 Expiration date of Option (right to buy)

First vesting tranche 66,667 options Vest on May 10, 2026

Second vesting tranche 66,667 options Vest on May 10, 2027

Final vesting tranche 66,666 options Vest on May 10, 2028

Key Terms

Form 3, self-managed superannuation fund, Option (right to buy, vesting

4 terms

Form 3 regulatory

"Lynette Elizabeth Cobley filed an initial Form 3 showing her existing equity stake."

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

self-managed superannuation fund financial

"held indirectly through Synergy Finance Pty Ltd as trustee for her self-managed superannuation fund."

Option (right to buy financial

"She also holds an option over 200,000 Ordinary Shares at an exercise price"

vesting financial

"these options were granted on May 10, 2025 and vest in three annual tranches"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Mesoblast (MESO) Form 3 filed by Lynette Cobley show?

The Form 3 shows Lynette Cobley’s existing Mesoblast holdings. She reports 30,000 Ordinary Shares directly, 33,000 Ordinary Shares indirectly via a superannuation trust, and an option over 200,000 Ordinary Shares at a $1.72 exercise price expiring in 2032.

How many Mesoblast (MESO) shares does Lynette Cobley hold directly and indirectly?

Lynette Cobley reports 30,000 Mesoblast Ordinary Shares held directly and 33,000 Ordinary Shares held indirectly. The indirect position is held by Synergy Finance Pty Ltd as trustee for her self-managed superannuation fund, reflecting personal retirement-related ownership.

What options over Mesoblast (MESO) shares does Lynette Cobley report on Form 3?

She reports an option over 200,000 Mesoblast Ordinary Shares with a $1.72 exercise price per share and a May 9, 2032 expiration date. The option represents a right to buy future shares if vesting and exercise conditions are met.

What is the vesting schedule of Lynette Cobley’s Mesoblast (MESO) options?

The footnote states the option was granted May 10, 2025 and vests in three tranches: 66,667 options vest May 10, 2026; another 66,667 vest May 10, 2027; and 66,666 vest May 10, 2028, subject to the grant’s terms.

How are Lynette Cobley’s indirect Mesoblast (MESO) holdings structured?

Her 33,000 indirectly held Ordinary Shares are owned by Synergy Finance Pty Ltd as trustee for her self-managed superannuation fund. This structure means the shares are held within a retirement-focused trust rather than directly in her personal name.

Does the Mesoblast (MESO) Form 3 show any recent buy or sell transactions by Lynette Cobley?

The Form 3 presents Cobley’s beneficial ownership as of becoming a reporting person and categorizes the entries as holdings. The transaction summary shows no buy or sell transactions, only three holding entries and a neutral net buy/sell direction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/29/2026 - 06:02 AM EDT Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

COBLEY LYNETTE ELIZABETH

(Last) (First) (Middle)

LEVEL 38

55 COLLINS STREET

(Street)

MELBOURNE, VICTORIA 3000

(City) (State) (Zip)

AUSTRALIA

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
MESOBLAST LTD [ MESO ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares	30,000	D
Ordinary Shares	33,000	I	By Synergy Finance Pty Ltd as trustee for Ms Cobley's self-managed superannuation fund.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option (right to buy)	(1)	05/09/2032	Ordinary Shares	200,000	$1.72	D

Explanation of Responses:

1. Granted on May 10, 2025. 66,667 options will vest on May 10, 2026, 66,667 options will vest on May 10, 2027, and 66,666 options will vest on May 10, 2028.

Remarks:

There are no derivative securities beneficially owned.

	/s/ Lynette Elizabeth Cobley	04/29/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)